Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Indications Expanded for Antifungal AmBisome In Spain BOULDER, CO -- June 11, 1998 -- The Spanish Ministry of Health has approved expanded indications for NeXstar Pharmaceuticals Inc.’s AmBisome, a liposomal formulation of amphotericin B. The new, broader label now includes first-line treatment in severe confirmed systemic fungal infections; empirical treatment for fungal infections in severely neutropenic patients; and treatment for visceral leishmaniasis in immune-compromised patients who have failed amphotericin B or other conventional therapy. The new label in Spain recommends that AmBisome therapy should be administered at doses of 1 to 3 mg/kg/day. In specific cases of extremely severe fungal infections, doses up to 5 mg/kg/day may be used. AmBisome now has first line indications in 16 countries world-wide. Patients at risk for systemic (blood-borne) fungal infections include those with compromised immune systems, such as patients receiving cancer treatment, HIV-infected individuals and bone marrow transplant patients. Patients afflicted with systemic fungal infections have low levels of infection-fighting white blood cells and exhibit persistent fever that does not resolve despite large-spectrum antibiotic treatment. These fungal infections are often lethal in the absence of effective therapy. More information on: AmBisome, NeXstar Pharmaceuticals Inc. E-mail this page to a friend or colleague! To print, use this version